Diallyl Trisulfide Regulates Cell Apoptosis and Invasion in Human Osteosarcoma U2OS Cells Through Regulating PI3K/AKT/GSK3β Signaling Pathway

Overview

Journal Histol Histopathol

Specialties Anatomy & Histology
Pathology

Date 2020 Dec 29

PMID 33372687

Citations 6

Authors

Pan He

Zhijun Wang

Bin Sheng

Yongqiang Xu

Siyin Feng

Yan Huang

Fuqiang Gong

Liting Tang

Liming Xie

Affiliations

Soon will be listed here.

Abstract

Aims: To investigate the effects and the mechanisms of action of Diallyl trisulfide (DATS) on the proliferation and metastasis of human osteosarcoma (OS) U2OS.

Methods: U2OS cells were treated by different concentrations of DATS at different time points. Cell proliferations were measured by MTT assay. DATS induced cell cycle distribution and apoptosis were evaluated by flow cytometry (FCM) with Annexin-V. Cell migration and invasion were detected by wound healing assay and transwell assay. The effects of DATS in U2OS cell growth and metastasis were also detected in a mouse OS xenograft model.

Results: A time- and concentration-dependent cytotoxic effect of DATS was observed in U2OS cells. FCM with PI staining and Annexin-V -FITC indicated that DATS induces apoptosis and a G0/G1 cell cycle arrest of U2OS cells at all concentrations from 25 μmol/l to 100 μmol/l. DATS also inhibits the migration and invasion of U2OS cells. Western blot showed that the expression levels of p-AKT, p-GSK3β, Bcl-2, Vimentin and β-catenin were decreased, while the expression levels of Bad, Bax and E-cadherin were significantly increased in DATS treated U2OS cells. Analysis using a mouse xenograft model indicated that xenografts of DATS treatment group had a significant decrease in tumor volume and weight compared to the control group. Lung metastasis models in mice demonstrated that treatment of DATS inhibits lung metastasis of OS in vivo.

Conclusions: These data suggested that DATS inhibits OS development and progression through the regulation of PI3K/AKT/GSK3β signaling pathways, accompanied by downregulation of Bcl-2, Vimentin and β-catenin, as well as upregulation of Bad, Bax and E-cadherin. Therefore, our data demonstrated that DATS exerted its anticancer effects by inhibiting cell proliferation, migration and invasion in vitro and in vivo. These results provide evidence for the use of the natural product DATS either alone or in combination with standard therapy for OS.

Citing Articles

The potential of diallyl trisulfide for cancer prevention and treatment, with mechanism insights.

Lu L, Gao Z, Song J, Jin L, Liang Z Front Cell Dev Biol. 2024; 12:1450836.

PMID: 39403128 PMC: 11471646. DOI: 10.3389/fcell.2024.1450836.

Diallyl trisulfide inhibits osteosarcoma 143B cell migration, invasion and EMT by inducing autophagy.

Liu X, Wang N, He Z, Chen C, Ma J, Liu X Heliyon. 2024; 10(5):e26681.

PMID: 38434350 PMC: 10907726. DOI: 10.1016/j.heliyon.2024.e26681.

The Anticancer Effects of the Garlic Organosulfide Diallyl Trisulfide through the Attenuation of B[a]P-Induced Oxidative Stress, AhR Expression, and DNA Damage in Human Premalignant Breast Epithelial (MCF-10AT1) Cells.

Ferguson D, Taka E, Tilghman S, Womble T, Redmond B, Gedeon S Int J Mol Sci. 2024; 25(2.

PMID: 38255999 PMC: 10815401. DOI: 10.3390/ijms25020923.

NOTCH Signaling in Osteosarcoma.

Zhang Z, Wu W, Shao Z Curr Issues Mol Biol. 2023; 45(3):2266-2283.

PMID: 36975516 PMC: 10047431. DOI: 10.3390/cimb45030146.

A Water-Soluble Hydrogen Sulfide Donor Suppresses the Growth of Hepatocellular Carcinoma via Inhibiting the AKT/GSK-3/-Catenin and TGF-/Smad2/3 Signaling Pathways.

Duan S, Zhang M, Dong Q, Yang B, Liu W, Zhang X J Oncol. 2023; 2023:8456852.

PMID: 36925651 PMC: 10014162. DOI: 10.1155/2023/8456852.

References

Anderson M . Update on Survival in Osteosarcoma. Orthop Clin North Am. 2015; 47(1):283-92. DOI: 10.1016/j.ocl.2015.08.022. View

Bielack S, Hecker-Nolting S, Blattmann C, Kager L . Advances in the management of osteosarcoma. F1000Res. 2016; 5:2767. PMC: 5130082. DOI: 10.12688/f1000research.9465.1. View

Chandra-Kuntal K, Lee J, Singh S . Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic. Breast Cancer Res Treat. 2013; 138(1):69-79. PMC: 3594460. DOI: 10.1007/s10549-013-2440-2. View

Chen J, Huang X, Wang Q, Huang J, Zhang L, Chen X . Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer. Carcinogenesis. 2012; 34(1):10-9. DOI: 10.1093/carcin/bgs274. View

Chen N, Zhang R, Konishi T, Wang J . Upregulation of NRF2 through autophagy/ERK 1/2 ameliorates ionizing radiation induced cell death of human osteosarcoma U-2 OS. Mutat Res Genet Toxicol Environ Mutagen. 2016; 813:10-17. DOI: 10.1016/j.mrgentox.2016.11.006. View

Cheng D, Yu T, Hu T, Yao M, Fan C, Yang Q . MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1. Oncotarget. 2015; 6(40):42761-72. PMC: 4767468. DOI: 10.18632/oncotarget.6199. View

Cui Y, Jiang D, Zhang S, Wu P, Ye Y, Chen C . FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways. Cancer Lett. 2014; 353(1):87-94. DOI: 10.1016/j.canlet.2014.07.008. View

Daniele S, Costa B, Zappelli E, Da Pozzo E, Sestito S, Nesi G . Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells. Sci Rep. 2015; 5:9956. PMC: 4404683. DOI: 10.1038/srep09956. View

Friebele J, Peck J, Pan X, Abdel-Rasoul M, Mayerson J . Osteosarcoma: A Meta-Analysis and Review of the Literature. Am J Orthop (Belle Mead NJ). 2015; 44(12):547-53. View

10.

Grille S, Bellacosa A, Upson J, Klein-Szanto A, van Roy F, Lee-Kwon W . The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 2003; 63(9):2172-8. View

11.

Klein M, Siegal G . Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006; 125(4):555-81. DOI: 10.1309/UC6K-QHLD-9LV2-KENN. View

12.

Lai K, Hsu S, Yang J, Yu C, Lein J, Chung J . Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth. J Cell Mol Med. 2014; 19(2):474-84. PMC: 4407594. DOI: 10.1111/jcmm.12486. View

13.

Lee J, Dedhar S, Kalluri R, Thompson E . The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006; 172(7):973-81. PMC: 2063755. DOI: 10.1083/jcb.200601018. View

14.

Li J, Liu W, Zhao K, Zhang Y, Li X, Yang Q . Diallyl trisulfide reverses drug resistance and lowers the ratio of CD133+ cells in conjunction with methotrexate in a human osteosarcoma drug-resistant cell subline. Mol Med Rep. 2011; 2(2):245-52. DOI: 10.3892/mmr_00000091. View

15.

Li Y, Zhang J, Zhang L, Si M, Yin H, Li J . Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. Carcinogenesis. 2013; 34(7):1601-10. DOI: 10.1093/carcin/bgt065. View

16.

Liu K, Sun X, Zhang Y, Liu L, Yuan Q . MiR-598: A tumor suppressor with biomarker significance in osteosarcoma. Life Sci. 2017; 188:141-148. DOI: 10.1016/j.lfs.2017.09.003. View

17.

Liu Y, Zhu P, Wang Y, Wei Z, Tao L, Zhu Z . Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways. PLoS One. 2015; 10(4):e0123781. PMC: 4415928. DOI: 10.1371/journal.pone.0123781. View

18.

Mackall C, Merchant M, Fry T . Immune-based therapies for childhood cancer. Nat Rev Clin Oncol. 2014; 11(12):693-703. PMC: 6953414. DOI: 10.1038/nrclinonc.2014.177. View

19.

Na H, Kim E, Choi M, Park J, Kim D, Surh Y . Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1. Biochem Pharmacol. 2012; 84(10):1241-50. DOI: 10.1016/j.bcp.2012.08.024. View

20.

Powolny A, Singh S . Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer Lett. 2008; 269(2):305-14. PMC: 2562004. DOI: 10.1016/j.canlet.2008.05.027. View